Trial reportBrazilian dental journal2026
Salivary fluoride bioavailability after application of fluoride varnishes: A randomized clinical study.
Trial report in Brazilian dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the bioavailability of F in saliva compartments (sediment and supernatant) after the use of fluoride varnishes (FV) with 5% sodium fluoride. In this randomized two-phase crossover clinical study, 15 participants were allocated into two groups and received application of Duraphat® and Fluorniz on the vestibular surface of the teeth. Unstimulated saliva was collected before the application of the FV, and 5 min, 15 min, 30 min, 1 h, 2 h, 4 h, 8 h, 12 h, 24 h, 48 h, and 96 h after application. For statistical analysis, a t-test was performed to compare the FV in the salivary compartments. The F in saliva at different times was compared with the baseline using analysis of variance, with Dunnett's post hoc test for multiple comparisons. After application, the F concentration in the salivary compartments increased (p < 0.001) and returned to baseline 24 h after application in the Duraphat® group and 8 h after application in the Fluorniz group. When comparing the salivary sediment and supernatant, there was a difference between the FV up to 48 h after application, with higher F concentrations observed in the Duraphat® group. The availability of F was higher after the use of Duraphat® (p < 0.05). The application of Duraphat® and Fluorniz increased the F concentration in saliva, and Fluorniz presented lower F bioavailability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.